Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Muzzi

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Human Vaccines & Immunotherapeutics|April 13, 2021
High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007-2011: Concordant predictions between MATS and genetic MATSSarah J Tozer, Helen V Smith, David M Whiley, et al.
Nature Biotechnology|August 13, 2002
Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarraysRenata Grifantini, Erika Bartolini, Alessandro Muzzi, et al.
Human Vaccines & Immunotherapeutics|July 22, 2024
Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 <i>Neisseria meningitidis</i> isolates causing invasive meningococcal disease in Argentina in 2010-2014Adriana Efron, Alessandro Brozzi, Alessia Biolchi, et al.
Infection and Immunity|December 15, 2010
Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodiesKate L Seib, Brunella Brunelli, Barbara Brogioni, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2010
Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccinesJohn Donnelly, Duccio Medini, Giuseppe Boccadifuoco, et al.
Frontiers in Immunology|November 25, 2021
Dissecting the Human Response to <i>Staphylococcus aureus</i> Systemic InfectionsRosanna Leuzzi, Margherita Bodini, Isaac P Thomsen, et al.
Genome Biology|November 2, 2010
Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related speciesClaudio Donati, N Luisa Hiller, Hervé Tettelin, et al.
Vaccine|May 17, 2011
Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United StatesXin Wang, Amanda Cohn, Maurizio Comanducci, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2016
Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determinedMassimiliano Biagini, Marco Spinsanti, Gabriella De Angelis, et al.
Vaccine|January 22, 2019
Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwideAlessandro Muzzi, Alessandro Brozzi, Laura Serino, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Human Vaccines & Immunotherapeutics|April 13, 2021
High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007-2011: Concordant predictions between MATS and genetic MATSSarah J Tozer, Helen V Smith, David M Whiley, et al.
Nature Biotechnology|August 13, 2002
Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarraysRenata Grifantini, Erika Bartolini, Alessandro Muzzi, et al.
Human Vaccines & Immunotherapeutics|July 22, 2024
Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 <i>Neisseria meningitidis</i> isolates causing invasive meningococcal disease in Argentina in 2010-2014Adriana Efron, Alessandro Brozzi, Alessia Biolchi, et al.
Infection and Immunity|December 15, 2010
Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodiesKate L Seib, Brunella Brunelli, Barbara Brogioni, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2010
Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccinesJohn Donnelly, Duccio Medini, Giuseppe Boccadifuoco, et al.
Frontiers in Immunology|November 25, 2021
Dissecting the Human Response to <i>Staphylococcus aureus</i> Systemic InfectionsRosanna Leuzzi, Margherita Bodini, Isaac P Thomsen, et al.
Genome Biology|November 2, 2010
Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related speciesClaudio Donati, N Luisa Hiller, Hervé Tettelin, et al.
Vaccine|May 17, 2011
Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United StatesXin Wang, Amanda Cohn, Maurizio Comanducci, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2016
Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determinedMassimiliano Biagini, Marco Spinsanti, Gabriella De Angelis, et al.
Vaccine|January 22, 2019
Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwideAlessandro Muzzi, Alessandro Brozzi, Laura Serino, et al.
Pageof 7